What is Leerink Partnrs’ Estimate for MLTX Q1 Earnings?
MoonLake Immunotherapeutics (NASDAQ:MLTX – Free Report) – Leerink Partnrs issued their Q1 2025 earnings per share estimates for shares of MoonLake Immunotherapeutics in a research note issued to investors on Thursday, February 27th. Leerink Partnrs analyst T. Smith expects that the company will earn ($0.82) per share for the quarter. The consensus estimate for MoonLake […]
MoonLake Immunotherapeutics (NASDAQ:MLTX – Free Report) – Leerink Partnrs issued their Q1 2025 earnings per share estimates for shares of MoonLake Immunotherapeutics in a research note issued to investors on Thursday, February 27th. Leerink Partnrs analyst T. Smith expects that the company will earn ($0.82) per share for the quarter. The consensus estimate for MoonLake […]
-etf-logo-1200x675.png?v=20240612131721&w=240&h=240&zc=2){kind=logo}
